Approval belongs to a named product and use
The Food and Drug Administration (FDA) ties its review of a product’s evidence to a specified use. “Peptide” by itself is not an approval status.
As of September 2026, semaglutide (Ozempic, Wegovy) has approved products for uses including diabetes care and weight management. The brand and form matter when checking the approved use.
A custom version has a different evidence gap
Before a compounded preparation is offered, FDA has not reviewed whether it is safe, effective or of suitable quality. Compounded means prepared to order, rather than provided as a finished product with approval.
FDA’s advertising guidance rejects claims that a compounded drug is a generic or has been proved to give the same result as the approved product.
A brand medicine can have an approved copy; that copy is a generic. It is not another word for a custom preparation.
Ask what the result really measures
- Does the evidence concern this exact product?
- Was the claim about the problem I want help with?
- Which result did the study measure, and how much change would help in my situation?
Keep weight change, injury recovery and sport performance as separate questions. Ask the person making the claim to show the source for the result they name.
An official product number does not prove approval
An NDC number is a code that identifies a drug in a government list. If an offer points to that number as proof of approval, FDA says the number does not prove it.